SurveyWFIKKN1 and WFIKKN2: “Companion” proteins regulating TGFB activity

- WFIKKN1 and WFIKKN2 function is not limited to inhibition of MSTN and GDF11 in muscle and skeletal tissues.
- WFIKKN1 and WFIKKN2 provide localized and sustained presentation of various TGFB proteins to their respective type II receptors resulting in specific growth factor patterns.
- WFIKKN1 and WFIKKN2 control the balance between the activation by TGFB of Smad and non-Smad pathways via an inhibition of type I receptor recruitment.

The WFIKKN (WAP, Follistatin/kazal, Immunoglobulin, Kunitz and Netrin domain-containing) protein family is composed of two multidomain proteins: WFIKKN1 and WFIKKN2. They were formed by domain shuffling and are likely present in deuterostoms. The WFIKKN (also called GASP) proteins are well known for their function in muscle and skeletal tissues, namely, inhibition of certain members of the transforming growth factor beta (TGFB) superfamily such as myostatin (MSTN) and growth and differentiation factor 11 (GDF11). However, the role of the WFIKKN proteins in other tissues is still poorly understood in spite of evidence suggesting possible action in the inner ear, brain and reproduction. Further, several recent studies based on next generation technologies revealed differential expression of WFIKKN1 and WFIKKN2 in various tissues suggesting that their function is not limited to MSTN and GDF11 inhibition in musculoskeletal tissue. In this review, we summarize current knowledge about the WFIKKN proteins and propose that they are “companion” proteins for various growth factors by providing localized and sustained presentation of TGFB proteins to their respective receptors, thus regulating the balance between the activation of Smad and non-Smad pathways by TGFB.

206